78
Participants
Start Date
November 3, 2017
Primary Completion Date
September 13, 2023
Study Completion Date
March 3, 2035
Patient-derived CD19- and CD22 specific CAR
Patient-derived CD19-specific CAR also expressing an HER2t and CD22-specific CAR T-cells also expressing an EGFRt
Children's National Medical Center, Washington D.C.
Riley Hospital for Children, Indianapolis
Children's Hospital Los Angeles, Los Angeles
Seattle Children's Hospital, Seattle
Children's and Women's Health Centre of British Columbia, Vancouver
Seattle Children's Hospital
OTHER